Establishment of two distinct anti-cardiolipin antibody-producing cell lines from the same individual by Epstein-Barr virus transformation.

[1]  T. Sumida,et al.  Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. , 1992, Journal of immunology.

[2]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Walport,et al.  Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis , 1990, Clinical and experimental immunology.

[4]  I. Hasegawa,et al.  Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody. , 1990, Journal of reproductive immunology.

[5]  C. Chesterman,et al.  Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics , 1989, British journal of haematology.

[6]  A. Wiik,et al.  The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus. , 1989, Clinical and experimental immunology.

[7]  D. Tsakiris,et al.  Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant , 1989, Thrombosis and Haemostasis.

[8]  M. Khamashta,et al.  Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. , 1988, Clinical and experimental immunology.

[9]  J. Wautier,et al.  IgG Binding to Endothelial Cells in Systemic Lupus Erythematosus , 1986, Thrombosis and Haemostasis.

[10]  J. Freyssinet,et al.  An IgM Lupus Anticoagulant that Neutralizes the Enhancing Effect of Phospholipid on Purified Endothelial Thrombomodulin Activity-A Mechanism for Thrombosis , 1986, Thrombosis and Haemostasis.

[11]  G. Hughes,et al.  The anticardiolipin syndrome. , 1985, The Journal of rheumatology.

[12]  G. Ferrara,et al.  In vitro production of a human HLA alloantibody of restricted specificity (DQw2) via Epstein-Barr virus transformation. , 1986, Human immunology.

[13]  J. Fontcuberta,et al.  LUPUS ANTICOAGULANT, RECURRENT ABORTION, AND PROSTACYCLIN PRODUCTION BY CULTURED SMOOTH MUSCLE CELLS , 1983, The Lancet.

[14]  T. Cosgriff,et al.  Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. , 1981, Arthritis and rheumatism.

[15]  G. Klein,et al.  EB virus-induced B lymphocyte cell lines producing specific antibody , 1977, Nature.

[16]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.